We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dextromethorphan Prevents Circulatory Failure in Rats with Endotoxemia.
- Authors
Chien-Chuan Wang; Yen-Mei Lee; Hsiao-Ping Wei; Chin-Chen Chu; Mao-Hsiung Yen
- Abstract
Dextromethorphan (DM), an antitussive agent, has been claimed to have anti-inflammatory and immunomodulatory effects in vitro. Thus, the aim of this study was to evaluate the effects of DM on sepsis induced by intravenous (i.v.) administration of lipopolysaccharide (LPS) in anesthetized Wistar rats and by intraperitoneal administration in conscious ICR mice. Results demonstrated that pretreatment with DM (1, 5 and 10 mg/kg, i.v.) significantly attenuated the deleterious hemodynamic changes (e.g., hypotension and tachycardia) in rats treated with LPS. Meanwhile, DM (5 mg/kg) significantly inhibited the elevation of plasma tumor necrosis factor-α and interleukin-10 levels, as well as values of GOT and GPT (as an index of liver function), and BUN and creatinine (as an index of renal function) caused by LPS. The induction of inducible NO synthase and the overproduction of NO and superoxide anions by LPS were also reduced by DM. Moreover, infiltration of neutrophils into the lungs and liver of rats 6 h after treatment with LPS was also reduced by DM. In conclusion, the beneficial effects of DM on LPS-induced sepsis result from its anti-inflammatory and antioxidant effects. Thus, DM can possibly be used as a prophylactic agent for sepsis in the future. Copyright © 2004 National Science Council, ROC and S. Karger AG, Basel
- Subjects
ENDOTOXINS; TUMOR necrosis factors; NITRIC oxide; ANIONS; NEUTROPHILS
- Publication
Journal of Biomedical Science, 2004, Vol 11, Issue 6, p739
- ISSN
1021-7770
- Publication type
Article
- DOI
10.1007/BF02254358